Related references
Note: Only part of the references are listed.Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
Maryam Ahmadi et al.
PHARMACEUTICAL RESEARCH (2015)
Investigation of the Immunogenicity of Different Types of Aggregates of a Murine Monoclonal Antibody in Mice
Angelika J. Freitag et al.
PHARMACEUTICAL RESEARCH (2015)
That's cool! - Nebulization of thermolabile proteins with a cooled vibrating mesh nebulizer
Sebastian Hertel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Prediction of protein degradation during vibrating mesh nebulization via a high throughput screening method
Sebastian Hertel et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery
Moritz Beck-Broichsitter et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Capturing the Efficiency of Vibrating Mesh Nebulizers: Minimizing Upper Airway Deposition
Rex B. Sagalla et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
PEGylation of antibody fragments greatly increases their local residence time following delivery to the respiratory tract
Salome Juliette Koussoroplis et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system
L. Guilleminault et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Immunogenicity of therapeutic proteins: Influence of aggregation
Kirsty D. Ratanji et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Antibodies to watch in 2014
Janice M. Reichert
MABS (2014)
Antibodies to watch in 2014 Mid-year update
Janice M. Reichert
MABS (2014)
VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations
Virginie Herve et al.
MABS (2014)
Effect of formulation on the stability and aerosol performance of a nebulized antibody
Renaud Respaud et al.
MABS (2014)
Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy
Lee A. Davies et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice
C. Kliwinski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease GOLD Executive Summary
Jorgen Vestbo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Insulin-like growth factor-I aerosol formulations for pulmonary delivery
Oliver Germershaus et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Inhaled proteins: Challenges and perspectives
Flore Depreter et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Development and characterization of phospholipid-stabilized submicron aqueous dispersions of coenzyme Q10 presenting continuous vibrating-mesh nebulization performance
Thiago C. Carvalho et al.
JOURNAL OF LIPOSOME RESEARCH (2013)
The Discovery, Engineering and Characterisation of a Highly Potent Anti-Human IL-13 Fab Fragment Designed for Administration by Inhalation
Daniel Lightwood et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Characterization and quantitation of aggregates and particles in interferon- products: Potential links between product quality attributes and immunogenicity
James G. Barnard et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers
Moritz Beck-Broichsitter et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development?
Rong Deng et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice
Vasco Filipe et al.
MABS (2012)
Can anti-IgE therapy prevent airway remodeling in allergic asthma?
K. F. Rabe et al.
ALLERGY (2011)
Nanobodies®: New ammunition to battle viruses
Peter Vanlandschoot et al.
ANTIVIRAL RESEARCH (2011)
Optimizing Therapeutic Antibody Function Progress with Fc Domain Engineering
Etsuji Kaneko et al.
BIODRUGS (2011)
Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
Guillaume Cartron et al.
CLINICAL CANCER RESEARCH (2011)
Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
Etienne Lemarie et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2011)
A Technical Feasibility Study of Dornase Alfa Delivery with eFlow (R) Vibrating Membrane Nebulizers: Aerosol Characteristics and Physicochemical Stability
Thomas Scherer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
Agnes Maillet et al.
PHARMACEUTICAL RESEARCH (2011)
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Ron J. Keizer et al.
CLINICAL PHARMACOKINETICS (2010)
An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G
Devin B. Tesar et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
Immunogenicity of therapeutics: a matter of efficacy and safety
Andreas Nechansky et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Surface active drugs significantly alter the drug output rate from medical nebulizers
A. Arzhavitina et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Formulation strategy and use of excipients in pulmonary drug delivery
Gabrielle Pilcer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Evaluation of Lung Tolerance of Ethanol, Propylene Glycol, and Sorbitan Monooleate as Solvents in Medical Aerosols
Jerome Montharu et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2010)
Neonatal Fc Receptor: From Immunity to Therapeutics
Timothy T. Kuo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Have we overestimated the benefit of human(ized) antibodies?
Daniel R. Getts et al.
MABS (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel
Jose Hureaux et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Changes in Performance of the Pari eFlow (R) Rapid and Pari LC Plus (TM) during 6 Months Use by CF Patients
Bart L. Rottier et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)
Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis
Dominique Hubert et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients
Antoine Minne et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Global strategy for asthma management and prevention: GINA executive summary
E. D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Advanced Nebulizer Designs Employing Vibrating Mesh/Aperture Plate Technologies for Aerosol Generation
J. Waldrep et al.
Current Drug Delivery (2008)
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab
Agnes Maillet et al.
PHARMACEUTICAL RESEARCH (2008)
Studies on aerosol delivery of plasmid DNA using a mesh Nebulizer
Eugene R. Arulmuthu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2007)
Performance of the vibrating membrane aerosol generation device:: Aeroneb micropump nebulizer™
Guifang Zhang et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2007)
The influence of fluid physicochemical properties on vibrating-mesh nebulization
Thu Ghazanfari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Does repeated disinfection of the e-Flow rapid® nebulizer affect in vitro performance?
Lasha Bakuridze et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: Formulation aspects and stability
Elke Kleemann et al.
PHARMACEUTICAL RESEARCH (2007)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations
Stefanie Schuele et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Rationale for the selection of an aerosol delivery system for gene delivery
Yvonne K. Lentz et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2006)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery
Sunday A. Shoyele et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Expression and transport functionality of FcRn within rat alveolar epithelium: A study in primary cell culture and in the isolated perfused lung
M Sakagami et al.
PHARMACEUTICAL RESEARCH (2006)
Pharmacokinetics of intravenous immunoglobulin: A systematic review
Tamar Koleba et al.
PHARMACOTHERAPY (2006)
Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway
JA Dumont et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2005)
Immunogenicity of engineered antibodies
WYK Hwang et al.
METHODS (2005)
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
S Holgate et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin G
M Maury et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules
C Lombry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Rational design of solid aerosols for immunoglobulin delivery by modulation of aerodynamic and release characteristics
L Dellamary et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Complement function in mAb-mediated cancer immunotherapy
KA Gelderman et al.
TRENDS IN IMMUNOLOGY (2004)
Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers
KJ Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Paul Ehrlich - in search of the magic bullet
F Winau et al.
MICROBES AND INFECTION (2004)
Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway
AJ Bitonti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effect of excipients on the stability and aerosol performance of nebulized aviscumine
H Steckel et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2003)
Immunoglobulin transport across polarized epithelial cells
R Rojas et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung
GM Spiekermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys
TK Hart et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Consensus statement: Aerosols and delivery devices
MB Dolovich et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2000)
Monoclonal antibody therapy for solid tumors
MC Green et al.
CANCER TREATMENT REVIEWS (2000)
Share Paper
